Results 161 to 170 of about 2,755,321 (217)

Isoniazid Preventive Therapy Adherence and Its Predictors Among Soldiers on HIV Antiretroviral Therapy at a General Military Hospital in Uganda. [PDF]

HIV AIDS (Auckl)
Moses S, Mupere E, Nangendo J, Semitala FC, Kalyango JN, Chemonges S, Muwanguzi PA, Katamba A.   +7 more
europepmc   +1 more source

A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial. [PDF]

Lancet HIV, 2022
Kakande E, Christian C, Balzer LB, Owaraganise A, Nugent JR, DiIeso W, Rast D, Kabami J, Johnson Peretz J, Camlin CS, Shade SB, Geng EH, Kwarisiima D, Kamya MR, Havlir DV, Chamie G.   +15 more
europepmc   +1 more source

Tuberculosis screening, isoniazid preventive therapy coverage and factors associated with active TB diagnosis among people living with HIV at public health facilities of central Ethiopia. [PDF]

PLoS One
Aboma M, Abdisa B, Imana G, Taye K, Moti G, Fufa M.   +5 more
europepmc   +1 more source

Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial. [PDF]

Trials, 2023
Otero L, Zetola N, Campos M, Zunt J, Bayer A, Curisinche M, Ochoa T, Reyes M, Vega V, Van der Stuyft P, Sterling TR.   +10 more
europepmc   +1 more source

Can isoniazid preventive therapy be scaled up rapidly? Lessons learned in Kenya, 2014-2018. [PDF]

Int J Tuberc Lung Dis, 2021
Weyenga H, Karanja M, Onyango E, Katana AK, Ng Ang A LW, Sirengo M, Ondondo RO, Wambugu C, Waruingi RN, Muthee RW, Masini E, Ngugi EW, Shah NS, Pathmanathan I, Maloney S, De Cock KM.   +15 more
europepmc   +1 more source

Low completion rate for the 6-months course of isoniazid preventive therapy among people living with HIV, North Eastern Uganda, 2015-2017. [PDF]

Pan Afr Med J
Eurien D, Okethwangu D, Aliddeki DM, Kisaakye E, Nguna J, Bulage L, Mugerwa S, Ario AR.   +7 more
europepmc   +1 more source

Biomarker-confirmed suboptimal adherence to isoniazid preventive therapy among children with HIV in western Kenya. [PDF]

AIDS
Onyango DO, van der Sande MAB, Yuen CM, Were J, Mecha J, Njagi LN, Panpradist N, Matemo D, Leon D, Lutz B, Kinuthia J, John-Stewart G, Lacourse SM.   +12 more
europepmc   +1 more source

Impact of Isoniazid Preventive Therapy on Tuberculosis Incidence and Predictors of Tuberculosis Among People Living With HIV/AIDS at Debre Tabor General Hospital, Northwest Ethiopia. [PDF]

Tuberc Res Treat
Nigussie K, Gebeye E, Kifle ZD, Tadesse TY, Birarra MK.   +4 more
europepmc   +1 more source

Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester. [PDF]

Clin Infect Dis
Gupta A, Hughes MD, Cruz JL, Avihingsanon A, Mwelase N, Severe P, Omoz-Oarhe A, Masheto G, Moran L, Benson CA, Chaisson RE, Swindells S.   +11 more
europepmc   +1 more source

Drug-related pellagra in a Ugandan woman on isoniazid preventative therapy

IDCases, 2020
Sarah J. Coates, Amy W. Blasini, Patrick Musinguzi, Miriam Laker-Oketta   +3 more
openaire   +3 more sources